Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

Does BRIGATINIB Cause Product dose omission issue? 193 Reports in FDA Database

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

According to the FDA Adverse Event Reporting System (FAERS), 193 reports of Product dose omission issue have been filed in association with BRIGATINIB (Alunbrig). This represents 5.9% of all adverse event reports for BRIGATINIB.

193
Reports of Product dose omission issue with BRIGATINIB
5.9%
of all BRIGATINIB reports
18
Deaths
70
Hospitalizations

How Dangerous Is Product dose omission issue From BRIGATINIB?

Of the 193 reports, 18 (9.3%) resulted in death, 70 (36.3%) required hospitalization, and 2 (1.0%) were considered life-threatening.

Is Product dose omission issue Listed in the Official Label?

This adverse event is not currently listed in the official FDA drug label for BRIGATINIB. However, 193 reports have been filed with the FAERS database.

What Other Side Effects Does BRIGATINIB Cause?

Death (405) Non-small cell lung cancer (370) Off label use (256) Diarrhoea (239) Metastases to central nervous system (219) Nausea (218) Lung neoplasm malignant (216) Fatigue (201) Blood creatine phosphokinase increased (198) Neoplasm progression (172)

What Other Drugs Cause Product dose omission issue?

DUPILUMAB (18,189) USTEKINUMAB (9,405) GUSELKUMAB (9,267) LENALIDOMIDE (8,145) MEPOLIZUMAB (5,873) TOFACITINIB (5,646) VOXELOTOR (5,122) BELIMUMAB (4,671) SECUKINUMAB (4,572) APREMILAST (4,460)

Which BRIGATINIB Alternatives Have Lower Product dose omission issue Risk?

BRIGATINIB vs BRILINTA BRIGATINIB vs BRILIQUE BRIGATINIB vs BRIMONIDINE BRIGATINIB vs BRIMONIDINE\BRINZOLAMIDE BRIGATINIB vs BRIMONIDINE\TIMOLOL

Related Pages

BRIGATINIB Full Profile All Product dose omission issue Reports All Drugs Causing Product dose omission issue BRIGATINIB Demographics